The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Influence of induction chemotherapy (IC) in trimodality-eligible esophageal cancer patients: Secondary analysis of a randomized trial.
 
Yusuke Shimodaira
No Relationships to Disclose
 
Rebecca Slack
No Relationships to Disclose
 
Hsiang-Chun Chen
No Relationships to Disclose
 
Manoop S. Bhutani
No Relationships to Disclose
 
Jeffrey H Lee
No Relationships to Disclose
 
Brian Weston
No Relationships to Disclose
 
Elena Elimova
Employment - Merck (I)
 
Quan Lin
Employment - UCB (I)
Stock and Other Ownership Interests - UCB (I)
 
Kazuto Harada
No Relationships to Disclose
 
Fatemeh G Amlashi
No Relationships to Disclose
 
Dilsa Mizrak
No Relationships to Disclose
 
Mariela A. Blum
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst)
 
Jack A. Roth
Stock and Other Ownership Interests - Genprex
Consulting or Advisory Role - Genprex
Research Funding - Varian Medical Systems
Patents, Royalties, Other Intellectual Property - Genprex
 
Stephen Swisher
Consulting or Advisory Role - GlaxoSmithKline
Travel, Accommodations, Expenses - Memorial Sloan-Kettering Cancer Center
 
Heath Devin Skinner
No Relationships to Disclose
 
Wayne Lewis Hofstetter
No Relationships to Disclose
 
Ritsuko Komaki
No Relationships to Disclose
 
Garrett L. Walsh
No Relationships to Disclose
 
Jaffer A. Ajani
Honoraria - Bayer; Five Prime Therapeutics; Lilly/ImClone; Novartis
Research Funding - Amgen; Bristol-Myers Squibb; Delta-Fly Pharma; Lilly/ImClone; MedImmune; Merck; Novartis; Roche/Genentech; Taiho Pharmaceutical
Patents, Royalties, Other Intellectual Property - I have research funding from: Genentech, Roche, BMS, Taiho, MedImmune, Merck, Amgen, Lilly
Travel, Accommodations, Expenses - Bayer; Five Prime Therapeutics; Novartis